These results also provide evidences that Lnc-MALAT1 is a potential therapeutic target and plasma EVs-Lnc-MALAT1 is a potential diagnostic biomarker for liver fibrosis. This evidence concerns the gene MALAT1 and Hepatic fibrosis.